Dr. Moshe Levy, MD
What this data tells you about Dr. Levy
Dr. Moshe Levy is a medical oncology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Levy performed 35,628 Medicare services across 2,315 unique beneficiaries.
Between the years covered by Open Payments, Dr. Levy received a total of $4,760,026 from 68 pharmaceutical and/or device companies across 3284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 7,260 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 6,900 | $43 | $136 |
| Anti-nausea injection (fosaprepitant) | 4,800 | $0 | $5 |
| Daratumumab injection (Darzalex) | 3,060 | $38 | $127 |
| Paclitaxel chemotherapy injection | 3,037 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 2,904 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,014 | $0 | $1 |
| Comprehensive metabolic blood panel | 667 | $10 | $64 |
| Blood draw (venipuncture) | 636 | $8 | $20 |
| Complete blood count (CBC) with differential | 544 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 530 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 510 | $0 | $24 |
| Office visit, established patient (30-39 min) | 487 | $97 | $368 |
| Lactate dehydrogenase (enzyme) level | 217 | $6 | $31 |
| Complete blood count (CBC), automated | 196 | $6 | $34 |
| Microscopic examination for white blood cells with manual cell count | 195 | $4 | $22 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 189 | $23 | $157 |
| Measurement of immunoglobulin light chains | 188 | $17 | $60 |
| Ferritin level test (iron stores) | 179 | $13 | $60 |
| Office visit, established patient (20-29 min) | 174 | $62 | $250 |
| Iron level test | 172 | $6 | $27 |
| Iron binding capacity test | 172 | $9 | $35 |
| Administration of chemotherapy into vein, 1 hour or less | 165 | $104 | $707 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 160 | $3 | $373 |
| Immunoglobulin level test | 141 | $9 | $56 |
| Injection of additional new drug or substance into vein | 135 | $12 | $108 |
| Injection, carboplatin, 50 mg | 129 | $2 | $300 |
| Reticulated (young) platelet measurement | 70 | $35 | $143 |
| Injection, zoledronic acid, 1 mg | 68 | $7 | $431 |
| Administration of additional new drug or substance into vein, 1 hour or less | 65 | $51 | $344 |
| Basic metabolic blood panel | 60 | $8 | $49 |
| Injection, diphenhydramine hcl, up to 50 mg | 59 | $1 | $7 |
| Uric acid level test | 56 | $4 | $25 |
| Office visit, established patient, complex (40-54 min) | 56 | $141 | $496 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 50 | $50 | $313 |
| Drug injection, under skin or into muscle | 47 | $11 | $96 |
| Hospital follow-up visit, moderate complexity | 47 | $62 | $247 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $58 | $211 |
| New patient office visit, complex (60-74 min) | 33 | $162 | $709 |
| Unclassified drugs | 33 | $1 | $8 |
| Hospital follow-up visit, high complexity | 31 | $94 | $357 |
| Ct scan of chest with contrast | 27 | $48 | $821 |
| CT scan of abdomen and pelvis with contrast | 24 | $177 | $1,067 |
| Administration of chemotherapy into vein, each additional hour | 24 | $23 | $161 |
| Red blood count, automated test | 21 | $4 | $23 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 20 | $16 | $100 |
| Infusion, normal saline solution , 1000 cc | 20 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 14 | $16 | $94 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for medical oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Levy is a mixed practice specialist, with above-average Medicare volume (top 24% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Levy experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Levy receive payments from pharmaceutical companies?
How do Dr. Levy's costs compare to other medical oncologys in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology